Salomon & Ludwin’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.6K Buy
364
+67
+23% +$5.93K ﹤0.01% 695
2025
Q4
$26.4K Buy
297
+36
+14% +$3.01K ﹤0.01% 695
2025
Q3
$23.2K Buy
+261
New +$21K ﹤0.01% 725

Other funds holding ACLS

Salomon & Ludwin's ACLS Position: Q1 2026 in Review

Salomon & Ludwin increased its Axcelis (ACLS) stake by 23% in Q1 2026, buying an estimated $5.93K and bringing the position to 364 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Salomon & Ludwin first reported a position in ACLS in Q3 2025 and has held it in 3 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Salomon & Ludwin held 364 shares of Axcelis worth $34.6K as of Q1 2026.
  • Salomon & Ludwin bought 67 Axcelis shares in Q1 2026, an estimated $5.93K.
  • Axcelis made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #695 holding.
  • Salomon & Ludwin first reported a position in Axcelis in Q3 2025 and has held it in 3 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.